Last Posted: Jul 10, 2020
- Circulating biomarkers predictive of tumor response to cancer immunotherapy.
Lee Ernest Y et al. Expert review of molecular diagnostics 2019 19(10) 895-904 - Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
Patel Hitendra et al. Journal of hematology & oncology 2019 12(1) 130 - Clinical utility of plasma miR-371a-3p in germ cell tumors.
Mego Michal et al. Journal of cellular and molecular medicine 2019 23(2) 1128-1136 - Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance.
Schwartzberg Lee S et al. NPJ precision oncology 2020 415 - ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
A Dasari et al, Nature Rev Clin Oncol, July 6, 2020 - A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel-Trenaunay syndrome.
Palmieri Maria et al. Vascular 2020 Jun 1708538120936421 - Combining liquid biopsies and PET-CT for early cancer detection
SQ Wong et al, Nature Medicine, June 29, 2020 - Advances in the Detection Technologies and Clinical Applications of Circulating Tumor DNA in Metastatic Breast Cancer.
Liao Hao et al. Cancer management and research 2020 123547-3560 - Could tracking RNA in body fluids reveal disease?
E Dolgin, Nature Outlook, June 17, 2020 - Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
A Zviran et al, Nature Medicine, June 1, 2020
.png)
No hay comentarios:
Publicar un comentario